Citations 1
ILyAD (Indolent Lymphoma and Vitamin D): A phase III double blind, prospective randomized trial to evaluate the supplemental effect of vitamin D on progression-free survival in patients with low tumor-burden indolent non-Hodgkin lymphoma treated with ritux
Strawderman, Myla , Flowers, Christopher R. , Leonard, John P. , Peterson, Derick R., Friedberg, Jonathan W. , Brady, Michael, Kahl, Brad S. , Nastoupil, Loretta J. , Witzig, Thomas E.
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: TPS7587-TPS7587
